Literature DB >> 7724398

Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients.

G Altamura1, L Bianconi, F Lo Bianco, S Toscano, F Ammirati, C Pandozi, A Castro, M Cardinale, M Mennuni, M Santini.   

Abstract

External defibrillation is widely used for the termination of various atrial and ventricular tachyarrhythmias, including pacemaker patients. Our study was intended to evaluate the effects of DC shocks in 36 patients with unipolar pacemakers implanted in the right pectoral region (25 DDD, 10 VVI, 3 AAI). The shocks were delivered with paddles on the anterior surface of the thorax, as far as possible away from the pacemaker. The pacing output was programmed at 0.5 msec and 5 V (25 patients), 4 V (1 patient), and 2.5 V (10 patients). Transient loss of capture occurred in 18 patients (50%). These patients, compared with those without capture failure, received higher peak and cumulative shock energies, respectively, 216 +/- 99 versus 123 +/- 50 joules (P < 0.002) and 352 +/- 62 versus 147 +/- 98 joules (P < 0.004) and had a lower pacemaker pulse amplitude (4.0 +/- 1.2 vs 4.6 +/- 1.0 V, P = 0.11). Failure to capture lasted from 5 seconds to 30 minutes (mean 157 sec). In 15 patients the ventricular stimulation threshold was measured before and serially after cardioversion. A six-fold threshold increase was observed 3 minutes after the shock (P < 0.004) with gradual recovery to nearly baseline values at 24 hours. Transient sensing failure occurred in 7 of the 17 patients in whom it could be evaluated (41%). Furthermore, three cases of shock induced pacemaker malfunctions were observed requiring replacement of the stimulator in two patients. In conclusion, the incidence of loss of capture in pacemaker patients subjected to electrical cardioversion/defibrillation is high.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7724398     DOI: 10.1111/j.1540-8159.1995.tb02503.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

Review 1.  Electrical cardioversion of patients with implanted pacemaker or cardioverter-defibrillator: results of a survey of german centers and systematic review of the literature.

Authors:  J Lüker; A Sultan; T Plenge; J van den Bruck; C-H Heeger; S Meyer; K Mischke; R R Tilz; D Vollmann; G Nölker; B Schäffer; S Willems; D Steven
Journal:  Clin Res Cardiol       Date:  2017-11-18       Impact factor: 5.460

2.  Safety and efficacy of external electrical cardioversion in patients with left ventricular leads.

Authors:  Jakob Lüker; Georg von Bodman; Arian Sultan; Jürgen Brömsen; Ruken Ö Akbulak; Benjamin Schäffer; Doreen Schreiber; Boris A Hoffmann; Michael Block; Stephan Willems; Daniel Steven
Journal:  Clin Res Cardiol       Date:  2014-12-04       Impact factor: 5.460

3.  Evaluating the Efficacy and Safety of Internal Cardioversion with Implantable Cardioverter Defibrillator Device for Atrial Fibrillation in Systolic Heart Failure Patients.

Authors:  Hamza Sunman; Kudret Aytemir; Hikmet Yorgun; Uğur Canpolat; Muhammet Ulvi Yalçin; Naresh Maharjan; Serkan Asil; Levent Şahiner; Barış Kaya; Necla Özer; Ali Oto
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-06-18       Impact factor: 1.468

4.  Ventricular pacing thresholds following high-energy implantable cardioverter defibrillator shocks in integrated bipolar defibrillation systems.

Authors:  Yoshio Yamanouchi; Kei Miyoshi; Sunao Kodama; Yuhei Shiga; Shunichiro Sumi; Hideya Niimura; Hideaki Toujou; Hidenori Urata
Journal:  Exp Clin Cardiol       Date:  2009

5.  Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice.

Authors:  Roy Beinart; Saman Nazarian
Journal:  Circulation       Date:  2013-12-24       Impact factor: 29.690

6.  Electromagnetic interference on pacemakers.

Authors:  Okan Erdogan
Journal:  Indian Pacing Electrophysiol J       Date:  2002-07-01

Review 7.  Evaluation and Monitoring of Patients With Cardiovascular Implantable Electronic Devices Undergoing Noncardiac Surgery.

Authors:  Eduard Sklyar; Jonathan N Bella
Journal:  Health Serv Insights       Date:  2017-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.